Literature DB >> 11309629

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

M Kaul1, G A Garden, S A Lipton.   

Abstract

Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors) provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute. These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating these events offer hope for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309629     DOI: 10.1038/35073667

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  573 in total

Review 1.  Chemokines and central nervous system disorders.

Authors:  W J Karpus
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

2.  Subtypes of NMDA receptors in new-born rat hippocampal granule cells.

Authors:  Juan C Piña-Crespo; Alasdair J Gibb
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

Review 3.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 4.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

5.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

Review 6.  Eradication of human immunodeficiency virus from brain reservoirs.

Authors:  Avindra Nath
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

7.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

8.  Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.

Authors:  Deborrah Castillo; Thomas Ernst; Eric Cunningham; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-02       Impact factor: 4.147

9.  PMS777, a bis-interacting ligand for PAF receptor antagonism and AChE inhibition, attenuates PAF-induced neurocytotoxicity in SH-SY5Y cells.

Authors:  Juan Li; Biyun Shao; Liang Zhu; Yongyao Cui; Changzhi Dong; Jean-Marc Miezan Ezoulin; Xiaoling Gao; Qiushi Ren; Françoise Heymans; Hongzhuan Chen
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

10.  Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection.

Authors:  Candice C Clay; Denise S Rodrigues; Yan S Ho; Beth A Fallert; Kim Janatpour; Todd A Reinhart; Ursula Esser
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.